Total planned funding: $246,503,490
Allocations
Countries/Regions
| Eswatini | $246,503,490 |
Organizational Types
| Private Contractor | $56,792,142 |
| University | $48,321,388 |
| Unknown | $46,554,814 |
| NGO | $45,108,191 |
| Own Agency | $31,762,481 |
| Host Country Government Agency | $7,126,766 |
| Multi-lateral Agency | $6,918,202 |
| Other USG Agency | $1,621,664 |
| FBO | $1,538,242 |
| Implementing Agency | $759,600 |
Program Areas
| Care | $73,158,214 |
| Treatment | $55,402,425 |
| Prevention | $49,432,292 |
| Governance and Systems | $33,890,366 |
| Management and Operations | $20,161,823 |
| Testing | $14,458,370 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $40,767,472 |
| HBHC: Care: Adult Care and Support | $30,834,753 |
| HKID: Care: Orphans and Vulnerable Children | $21,667,906 |
| HVMS: Management and Operations | $20,161,823 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,465,524 |
| OHSS: Health Systems Strengthening | $14,541,227 |
| HVCT: Testing: HIV Testing and Counseling | $14,458,370 |
| HVTB: Care: TB/HIV | $14,103,240 |
| HVSI: Strategic Information | $13,748,638 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $10,763,941 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,696,667 |
| HTXD: Treatment: ARV Drugs | $9,379,165 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,457,374 |
| PDCS: Care: Pediatric Care and Support | $6,552,315 |
| HLAB: Laboratory Infrastructure | $5,600,501 |
| PDTX: Treatment: Pediatric Treatment | $5,255,788 |
| HMBL: Biomedical Prevention: Blood Safety | $2,048,786 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$46,051,827
Countries/Regions
Columbia University:
$43,424,103
Countries/Regions
Pact, Inc.:
$27,717,585
Countries/Regions
USG Aggregated Agencies:
$22,906,853
Countries/Regions